No photo of Flora Musuamba Tshinanu
Calculated based on number of publications stored in Pure and citations from Scopus
2009 …2203

Research activity per year

Network

Roger K. Verbeeck

  • Queensland University of Technology
  • Faculté de Medecine, UCL
  • Rhodes University

External person

Pierre Wallemacq

  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL
  • Louvain Center for Toxicology and Applied Pharmacology

External person

Efthymios Manolis

  • European Medicines Agency
  • EMA Modelling and Simulation Working Group

External person

Pierre E. Wallemacq

  • Faculté de Medecine, UCL
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Michel Mourad

  • Department of Endocrine Surgery
  • Université Catholique de Louvain
  • Faculté de Medecine, UCL
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Kristin E. Karlsson

  • European Medicines Agency
  • Medical Products Agency
  • EMA Modelling and Simulation Working Group

External person

Vincent Haufroid

  • Louvain Centre for Toxicology and Applied Pharmacology-Institut de Recherche Expérimentale et Clinique
  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels
  • Croix du Sud
  • Faculté de Medecine, UCL

External person

Isabelle Karine Delattre

  • Université Catholique de Louvain

External person

Ine Skottheim Rusten

  • EMA Modelling and Simulation Working Group
  • Norwegian Medicines Agency
  • European Medicines Agency
  • Systems Resource Lab

External person

Oscar Della Pasqua

  • School of Pharmacy
  • University College London
  • GlaxoSmithKline
  • Universiteit Leiden
  • Leiden Academic Centre for Drug Research

External person

Arnaud Capron

  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL
  • Sciensano

External person

Francesco Pappalardo

  • Università di Catania
  • Menzies Health Institute Queensland
  • Boston University

External person

Pierre Marquet

  • Université de Limoges
  • CHU Limoges

External person

Norbert Benda

  • EMA Modelling and Simulation Working Group
  • Federal Institute for Drugs and Medical Devices
  • European Medicines Agency
  • Bundesinstitut fur Arzneimittel und Medizinprodukte
  • Germany - BfArM

External person

Joseph Frank Standing

  • EMA Modelling and Simulation Working Group
  • University College London
  • European Medicines Agency

External person

Vanessa Guy-Viterbo

  • Cliniques Universitaires Saint-Luc, Brussels
  • Louvain Center for Toxicology and Applied Pharmacology
  • Faculté de Medecine, UCL

External person

Raymond Reding

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Fabio S Taccone

  • Université Libre de Bruxelles
  • Department of Pathology, Erasme Hospital

External person

Blanca Rodriguez

  • University of Oxford

External person

Susan Cole

  • EMA Modelling and Simulation Working Group
  • Medicines and Healthcare products Regulatory Agency
  • European Medicines Agency

External person

Pierre-François Laterre

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain
  • Universitair Ziekenhuis Brussel
  • Eli Lilly and Company
  • chu Lille
  • Faculté de Medecine, UCL
  • CHR Mons-Hainaut

External person

Valeria Gigante

  • EMA Modelling and Simulation Working Group
  • Italy - AIFA
  • European Medicines Agency

External person

Frédérique Jacobs

  • Department of Pathology, Erasme Hospital

External person

Raphaëlle Lesage

  • KULeuven
  • Virtual Physiological Human Institute

External person

Marco Viceconti

  • Alma Mater Studiorum Università di Bologna
  • Rizzoli Orthopaedic Institute
  • University of Sheffield

External person

Cécile Lescrainier

  • Federal Agency for Medicines and Health Products, Belgium

External person

Roberta Bursi

  • InSilicoTrials Technologies

External person

Johannes Taminiau

  • EMA Modelling and Simulation Working Group
  • Universitair Ziekenhuis Antwerpen
  • European Medicines Agency

External person

Françoise Wuillaume

  • Université Libre de Bruxelles
  • Federal Agency for Medicines and Health Products, Belgium

External person

Gerard Pons

  • EMA Modelling and Simulation Working Group
  • Université Denis Diderot Paris VII
  • European Medicines Agency

External person

Martine De Meyer

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Liesbet Geris

  • KULeuven
  • Virtual Physiological Human Institute
  • Université de Liège

External person

Jean-Cyr Yombi

  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL

External person

Rakan Nasreddine

  • Centre Hospitalier Universitaire Saint-Pierre
  • Université Libre de Bruxelles

External person

Frederike Lentz

  • EMA Modelling and Simulation Working Group
  • Federal Institute for Drugs and Medical Devices
  • European Medicines Agency
  • Germany - BfArM

External person

Veerle Verlinden

  • Federal Agency for Medicines and Health Products, Belgium

External person

S. Y. Amy Cheung

  • AstraZeneca
  • Certara, United Kingdom

External person

Alexander Kulesza

  • Novadiscovery

External person

Cécile F. Rousseau

  • Voisin Consulting Life Sciences

External person

Rossana Alessandrello

  • AQuAS - Agency for Health Quality and Assessment of Catalonia

External person

Jean Jacques Sennesael

  • Universitair Ziekenhuis Brussel

External person

Lucia Zhang

  • Health Canada

External person

Jean L. Cumps

  • Université Catholique de Louvain

External person

Giulia Russo

  • Università di Catania

External person

Gaby Wangorsch

  • European Medicines Agency
  • Paul-Ehrlich-Institut
  • EMA Modelling and Simulation Working Group

External person

Francesca Serone

  • EMA Modelling and Simulation Working Group
  • Italy - AIFA
  • European Medicines Agency

External person

Meindert Danhof

  • Leiden Academic Centre for Drug Research

External person

Sofia Friberg Hietala

  • Pharmetheus AB
  • European Medicines Agency
  • Medical Products Agency

External person

Emmanuelle M. Voisin

  • Voisin Consulting Life Sciences

External person

Anna Nordmark

  • EMA Modelling and Simulation Working Group
  • Medical Products Agency
  • European Medicines Agency

External person

Sung-Sen Yang

  • Triservice General Hospital Taiwan
  • GlaxoSmithKline

External person

Axel Facius

  • Nycomed GmbH

External person

Jean Louis Bosmans

  • Universitair Ziekenhuis Antwerpen

External person

Xavier Wittebole

  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL

External person

Justin L. Hay

  • EMA Modelling and Simulation Working Group
  • Medicines and Healthcare products Regulatory Agency
  • European Medicines Agency

External person

Hugo J. Maas

  • GlaxoSmithKline

External person

Salvatore D’Agate

  • University College London

External person

Wei Zhao

  • EMA Modelling and Simulation Working Group
  • Robert Debre University Hospital of Paris
  • Shandong University
  • European Medicines Agency

External person

Donato Teutonico

  • Leiden Academic Centre for Drug Research

External person

Nicolas Dauby

  • Université Libre de Bruxelles

External person

Michael J. Chappell

  • University of Warwick

External person

Martine Demeyer

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Colleen E. Clancy

  • University of California Davis

External person

Thomas Singer

  • F. Hoffmann-La Roche Ltd.

External person

Stefano Severi

  • Alma Mater Studiorum Università di Bologna

External person

Elin Haf Davies

  • Aparito Limited

External person

Zhilin Qu

  • University of California Los Angeles

External person

Anne Gaëlle Dosne

  • Bristol Myers Squibb

External person

Nicolas Frey

  • F. Hoffmann-La Roche Ltd.

External person

Pieter J. Colin

  • Academisch Ziekenhuis Groningen (UMCG)

External person

Tom M. Nanga

  • Université de Limoges

External person

Scott Marshall

  • GlaxoSmithKline

External person

Jan Lerut

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Monique Bodéus

  • Faculté de Medecine, UCL
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Antoine L. Buemi

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain
  • Faculté de Medecine, UCL

External person

Norisuke Kawai

  • Pfizer Inc.

External person

Andrew Thomson

  • European Medicines Agency

External person

Jian LI

  • National Medical Products Administration

External person

María Jesús Garrido

  • European Medicines Agency
  • Universidad de Navarra

External person

Bernard C. Vandercam

  • Faculté de Medecine, UCL

External person

Kayode Ogungbenro

  • School of Computer Science

External person

Nicholas H.G. Holford

  • The University of Auckland Business School

External person

Dominique Latinne

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Pavel Farkas

  • Teva Pharmaceuticals

External person

Leonid Kagan

  • Ernest Mario School of Pharmacy

External person

Falk Ehmann

  • European Medicines Agency

External person

Martin Vandeputte

  • Université Libre de Bruxelles

External person

Jeffrey S. Barret

  • Aridhia Bioinformatics

External person

Raphaël Denooz

  • Université de Liège, C.H.U.

External person

Mark Holbrook

  • Certara, United Kingdom

External person

Sara Berry

  • Berry Consultants

External person

Lionel Duck

  • Centre de Vaccinations
  • Clinique Saint-Pierre Ottignies

External person

Augusto Filipe

  • Tecnimede SA

External person

Andrew G. Edwards

  • University of California Davis

External person

Tom Darius

  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL

External person

Anne Moxhon

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Leila Belkhir

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain
  • Faculté de Medecine, UCL

External person

Lena E. Friberg

  • University of Uppsala

External person

Nuno Curado

  • Exploristics Ltd

External person

Jacob Brogren

  • EMA Modelling and Simulation Working Group
  • Medical Products Agency

External person

Michiel Van Den Heuvel

  • EMA Modelling and Simulation Working Group
  • Medicines Evaluation Board, Netherlands

External person

Anne Douhet

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Eleonora Grandi

  • University of California Davis

External person

Michelangelo Paci

  • TAMPEREEN YLIOPISTO

External person

Shinichi Kijima

  • Pharmaceuticals and Medical Devices Agency

External person

Xin Zhou

  • IEMN/ISEN Avenue Poincaré
  • Victor Chang Cardiac Research Institute

External person

Takashi Yoshinaga

  • Eisai Co., Ltd.

External person

Marc R. Gastonguay

  • Metrum Research Group

External person

Amit Roy

  • Bristol Myers Squibb

External person

Jun Shen

  • Bristol Myers Squibb

External person

Marc Delforge

  • Centre Hospitalier Universitaire Saint-Pierre
  • Université Libre de Bruxelles
  • University of Copenhagen

External person

Frederic Delaruelle

  • Waters Corporation, USA

External person

Feby Mardjuadi

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Stephan Frederic

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Nada Kanaan

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain
  • Faculté de Medecine, UCL

External person

Thao Thi Phuong Doan

  • Université de Limoges

External person

Paolo Tomasi

  • European Medicines Agency

External person

Faustine Lebout

  • Université Libre de Bruxelles
  • Centre Hospitalier Universitaire Saint-Pierre

External person

Alfonso Bueno-Orovio

  • University of California Davis
  • University of Oxford

External person

Ken Wang

  • F. Hoffmann-La Roche Ltd.

External person

Martin Posch

  • Kardiologische Universitätsklinik Wien

External person

Zhen Song

  • University of California Los Angeles

External person

Nicholas A. Buckley

  • Queensland University of Technology

External person

Chienlung Tu

  • Center for Drug Evaluation

External person

Bruce P. Damiano

  • Janssen Research & Development

External person

Philippe Henrivaux

  • Faculté de Medecine, UCL

External person

Fahim Mohammed

  • Queensland University of Technology

External person

Indika Gawarammana

  • Queensland University of Technology

External person

Jacques Medioni

  • Service d'Immunologie Biologique
  • Institut Curie

External person

Luc De Pauw

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain

External person

Victor Mangas Sanjuan

  • EMA Modelling and Simulation Working Group
  • Universidad de Valencia

External person

Piet Hein D. Van Der Graaf

  • Leiden Academic Centre for Drug Research
  • Certara, United Kingdom

External person

Sarem Sarem

  • Health Canada
  • University of Montreal

External person

Christophe Chardot

  • Hopital Necker

External person

Klintean Wunnapuk

  • Queensland University of Technology

External person

Cecile Ollivier

  • European Medicines Agency

External person

Françoise Van Bambeke

  • Louvain Drug Research Institute
  • Université Catholique de Louvain
  • Faculté de Medecine, UCL

External person

Michael S. Roberts

  • Queensland University of Technology

External person

Frank Bretz

  • Kardiologische Universitätsklinik Wien
  • Novartis

External person

Déborah Konopnicki

  • Centre Hospitalier Universitaire Saint-Pierre
  • Université Libre de Bruxelles
  • Hôpital Erasme, Bruxelles

External person

Enrico Dall’ara

  • University of Sheffield

External person

Eric A. Sobie

  • Icahn School of Medicine at Mount Sinai

External person

Loïc Schrooyen

  • Centre Hospitalier Universitaire Saint-Pierre
  • Université Libre de Bruxelles

External person

Bernard Lambermont

  • Université de Liège
  • Université de Liège, C.H.U.

External person

Adriana Ceci

  • Fondazione per la Ricerca Farmacologica Gianni Benzi onlus
  • Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus

External person

Haibo Ni

  • University of California Davis

External person

Patrick Goubau

  • Faculté de Medecine, UCL

External person

Robert James Hemmings

  • Medicines and Healthcare products Regulatory Agency

External person

Sihem Ait-Oudhia

  • Merck and Co

External person

Liudmila Polonchuk

  • F. Hoffmann-La Roche Ltd.

External person

Benoît Kabamba-Mukadi

  • Croix du Sud
  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL
  • UCL-CMFA 7340

External person

J.-L. RUELLE

  • Faculté de Medecine, UCL

External person

Aris Dokoumetzidis

  • EMA Modelling and Simulation Working Group
  • University of Athens

External person

Essam Kerwash

  • EMA Modelling and Simulation Working Group
  • Medicines and Healthcare products Regulatory Agency

External person

Sophie Kiridis

  • Federal Agency for Medicines and Health Products, Belgium

External person

Dominique Debray

  • Hopital Necker

External person

Juha Vakkilainen

  • EMA Modelling and Simulation Working Group
  • Finnish Medicines Agency

External person

Andrea Greiter-Wilke

  • F. Hoffmann-La Roche Ltd.

External person

Nathalie Layios

  • Université de Liège, C.H.U.
  • Saft

External person

Cécile Crozatier

  • Voisin Consulting Life Sciences

External person

Ralf Herold

  • European Medicines Agency

External person

Yasuto Otsubo

  • Pharmaceuticals and Medical Devices Agency

External person

Corinne Charlier

  • Université de Liège, C.H.U.

External person

Michel Moutschen

  • Université de Liège
  • Université de Liège, C.H.U.

External person

Henry Baudet

  • Hopital Necker

External person

Daisuke Iwata

  • Pharmaceuticals and Medical Devices Agency

External person

S Das

  • AstraZeneca

External person

Randall L. Rasmusson

  • Jacobs School of Medicine and Biomedical Sciences
  • State University of New York

External person

Thierry Dugernier

  • Centre de Vaccinations
  • Clinique Saint-Pierre Ottignies

External person

Anaïs Scohy

  • Cliniques Universitaires Saint-Luc, Brussels
  • Faculté de Medecine, UCL

External person

Adam Hill

  • Victor Chang Cardiac Research Institute
  • University of South Wales

External person

Pierre Paul Damas

  • Université de Liège, C.H.U.

External person

Armelle Duquenne

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Florence Lacaille

  • Hopital Necker

External person

Stephane Nave

  • F. Hoffmann-La Roche Ltd.

External person

Frédéric Frippiat

  • Université de Liège, C.H.U.

External person

Mikiko Nakamura

  • Chugai Pharmaceutical Co. Ltd.

External person

Julien De Greef

  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels
  • Hôpital Henri Mondor
  • AP-HP
  • CH Jolimont-Lobbes
  • Faculté de Medecine, UCL

External person

Michael B. Liu

  • University of California Los Angeles
  • David Geffen School of Medicine at UCLA

External person

Marie Francoise Vincent

  • International Institute of Cellular and Molecular Pathology
  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Derek J. Leishman

  • Eli Lilly and Company

External person

Roger Vanbinst

  • Cliniques Universitaires Saint-Luc, Brussels
  • Université Catholique de Louvain

External person

Godfrey Smith

  • Clyde Biosciences Ltd
  • University of Glasgow

External person

Mark C. Peterson

  • Vertex Pharmaceuticals, Inc.

External person

Luca Emili

  • InSilicoTrials Technologies

External person

Jiawei Wei

  • Novartis Institutes for Biomedical Research

External person

Elisa Passini

  • University of Oxford

External person

Peter Russell Kowey

  • Main Line Health
  • Thomas Jefferson University Medical College

External person

Marylene Clausse

  • St-Luc Bouge Clinic

External person

Joseph N. Kerger

  • CHU UCL Mont-Godinne-Dinant
  • Institut Jules Bordet

External person

Kevin-Alexandre Delongie

  • Université Catholique de Louvain
  • Cliniques Universitaires Saint-Luc, Brussels

External person

Jamie Vandenberg

  • Victor Chang Cardiac Research Institute
  • University of South Wales

External person

Minh Thuan Nguyen Thi

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Jean Luc Canon

  • Grand Hôpital de Charleroi (GHdC)

External person

Herbert Spapen

  • Universitair Ziekenhuis Brussel

External person

Chia Hsun Tsai

  • Center for Drug Evaluation

External person

Jin Y. Jin

  • Genentech, Inc

External person

Joakim Nyberg

  • University of Uppsala

External person

Julie Descy

  • Université de Liège, C.H.U.

External person

Laure Elens

  • Université Catholique de Louvain
  • Erasmus University Rotterdam
  • Louvain Drug Research Institute
  • Cliniques Universitaires Saint-Luc, Brussels
  • Croix du Sud

External person

Jean Pascal Machiels

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Evelyne M. Jacqz-Aigrain

  • Robert Debre University Hospital of Paris

External person

Erin Greene

  • Pfizer Inc.

External person

Agnès Libois

  • Université Libre de Bruxelles
  • Centre Hospitalier Universitaire Saint-Pierre
  • Universitat Autònoma de Barcelona (UAB)
  • Hospital Clinic Barcelona
  • Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hematopathology Unit, Hospital Clinic, CIBERONC, Barcelona, Spain

External person

Andrew C. Hooker

  • University of Uppsala

External person

Laurence Seidel

  • Université de Liège, C.H.U.

External person

Vincent Di Fazio

  • Cliniques Universitaires Saint-Luc, Brussels

External person

Neal Thomas

  • Pfizer Limited, UK

External person

Jean Louis Vincent

  • Department of Pathology, Erasme Hospital
  • Université Libre de Bruxelles

External person

Adelin I. Albert

  • Institut de Chimie
  • Université de Liège
  • Université de Liège, C.H.U.

External person

Stephane Oudard

  • Service d'Immunologie Biologique

External person

David D. Khan

  • EMA Modelling and Simulation Working Group
  • Medical Products Agency
  • University of Uppsala

External person

Gary R. Mirams

  • University of Nottingham

External person

Xin Liu

  • Queensland University of Technology

External person

Marc Horner

  • ANSYS, Inc.

External person

Marie-Christine Payen

  • Centre Hospitalier Universitaire Saint-Pierre
  • Université Libre de Bruxelles

External person

Jenny Y.L Chien

  • Eli Lilly and Company

External person

Aaron Fullerton

  • Genentech, Inc

External person

Anna Karin Hamberg

  • European Medicines Agency
  • Medical Products Agency

External person

Stefano Morotti

  • University of California Davis

External person

Muriel Girard

  • Hopital Necker

External person

Your message has successfully been sent.
Your message was not sent due to an error.